ATLASDirexion Daily S&P Biotech Bull 3X Shares (LABU): outlook, holdings and fees
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund and is managed by Direxion Funds. The expense ratio is 0.91% and the yield is 0.35%. The ten largest holdings are 4% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on LABU
| Last price | $229.60 (-7.1%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 45% |
| Likely 1-month range (50%) | $190.38 – $261.17 |
| Normal 1-day range (±1σ) | ±5.4% |
| Distribution yield | 0.35% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
LABU fund facts
| Issuer | Direxion Funds |
|---|---|
| Theme | Leveraged |
| Assets under management | $620M |
| Expense ratio | 0.91% |
| Number of holdings | 40 |
| Portfolio turnover | 0% |
| Inception | May 28, 2015 |
| Exchange | NYSE |
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.
LABU top holdings
| Holding | Sector | Weight |
|---|---|---|
| Moderna Inc MRNA | Healthcare | 0.56% |
| Twist Bioscience Corp TWST | Healthcare | 0.47% |
| Natera Inc NTRA | Healthcare | 0.44% |
| AbbVie Inc ABBV | Healthcare | 0.41% |
| United Therapeutics Corporation UTHR | Healthcare | 0.39% |
| Amgen Inc AMGN | Healthcare | 0.39% |
| Biogen Inc BIIB | Healthcare | 0.40% |
| Halozyme Therapeutics Inc HALO | Healthcare | 0.41% |
| Iovance Biotherapeutics Inc IOVA | Healthcare | 0.38% |
| Exelixis Inc EXEL | Healthcare | 0.40% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
LABU sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 99.3% |
| Financial Services | 0.7% |
By region: North America 96.7%, Europe Developed 2.0%, United Kingdom 1.3%.
LABU returns and risk
| Year to date | +46.5% |
|---|---|
| 1 year | +119.1% |
| 3 years (annualised) | +56.4% |
| 5 years (annualised) | -25.0% |
| 10 years (annualised) | -11.2% |
| Volatility (3 years) | 77.7% |
| Sharpe ratio (3 years) | 0.84 |
Past returns do not guarantee future results.
LABU: frequently asked questions
What does LABU invest in?
Direxion Daily S&P Biotech Bull 3X Shares invests in a portfolio of securities. Its largest holdings are Moderna Inc (0.6%), Twist Bioscience Corp (0.5%), Natera Inc (0.4%), AbbVie Inc (0.4%), United Therapeutics Corporation (0.4%).
What is the LABU expense ratio?
0.91% a year: about $91.00 for every $10,000 invested.
What is the LABU dividend yield?
0.35%. ATLAS does not hold the exact distribution dates for ETFs.
Will LABU go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 45%, with a likely range (50%) of $190.38 to $261.17 from $229.60 today. It is a probability, not a prediction.
How has LABU performed?
Year to date +46.5%, one year +119.1%, three years +56.4% a year, five years -25.0% a year. Past returns do not guarantee future results.
Similar ETFs: Leveraged
Educational information, not investment advice. Disclaimer